Showing results (1251-1260 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|July 21, 2022
Surface Plasmon Resonance Screening to Identify Active and Selective Adenosine Receptor Binding FragmentsClaire Shepherd, Sean Robinson, Alice Berizzi, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Development of Low-Molecular-Weight Compounds Targeting the Cancer-Associated KLF5 Transcription FactorTakeo Nakaya, Kenichi Aizawa, Yuki Taguchi, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Selective Macrocyclic Inhibitors of DYRK1A/BChelsea E Powell, John M Hatcher, Jie Jiang, et al.
ACS Medicinal Chemistry Letters|April 22, 2022
Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 InhibitorsChunhui Huang, Christian Fischer, Michelle R Machacek, et al.
ACS Medicinal Chemistry Letters|April 21, 2022
How a Blockchain Approach Can Improve Data Reliability in the COVID-19 PandemicPietro Cozzini, Federica Agosta, Greta Dolcetti, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Dendrigraft of Poly-l-lysine as a Promising Candidate To Reverse Heparin-based Anticoagulants in Clinical SettingsBenjamin Ourri, Jean-Patrick Francoia, Gerald Monard, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Modifications at Arg and Ile Give Neurotensin(8-13) Derivatives with High Stability and Retained NTS1 Receptor AffinityLisa Schindler, Günther Bernhardt, Max Keller
ACS Medicinal Chemistry Letters|February 3, 2022
Discovery of Dimeric Arylsulfonamides as Potent ADAM8 InhibitorsDoretta Cuffaro, Caterina Camodeca, Tiziano Tuccinardi, et al.
ACS Medicinal Chemistry Letters|February 18, 2022
Water-Soluble Nystatin and DerivativeAviran Amir, Michal Levin-Khalifa, Tamar Dvash
ACS Medicinal Chemistry Letters|February 18, 2022
Design, Synthesis, and Biological Evaluation of Apcin-Based CDC20 InhibitorsRajib Bhuniya, Xinrui Yuan, Longchuan Bai, et al.
Pageof 438